Dupilumab-Linked Vitiligo: Early Recognition and Alternative Agents
Research links dupilumab to new-onset vitiligo and points to early recognition, a nemolizumab switch, and targeted topical therapy. Case numbers and outcomes remain undisclosed.
Topic
Adverse Drug Reactions
Topic
Adverse Drug Reactions
GLP-1 Users Show Higher Nail Detachment and Discolouration Rates
A new study reported by Medical Dialogues links GLP-1 receptor agonist use to higher rates of onycholysis and nail discolouration…
Dapsone-Induced Methemoglobinemia: Dermatology's Outpatient Warning Signs
A pilot retrospective cohort study in Cureus examines the clinical indicators that should alert dermatologists to dapsone-induced…